LTIP1488A - Process for preparing pharmaceutical preparation for treating psoriatic diseases - Google Patents

Process for preparing pharmaceutical preparation for treating psoriatic diseases

Info

Publication number
LTIP1488A
LTIP1488A LTIP1488A LTIP1488A LTIP1488A LT IP1488 A LTIP1488 A LT IP1488A LT IP1488 A LTIP1488 A LT IP1488A LT IP1488 A LTIP1488 A LT IP1488A LT IP1488 A LTIP1488 A LT IP1488A
Authority
LT
Lithuania
Prior art keywords
pharmaceutical preparation
preparing pharmaceutical
treating psoriatic
psoriatic diseases
diseases
Prior art date
Application number
LTIP1488A
Inventor
Juergen Engel
Hansjoerg Eibl
Clemens Unger
Original Assignee
Asta Medica Ag
Max Planck Ges Zur Foergerung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6390272&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LTIP1488(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asta Medica Ag, Max Planck Ges Zur Foergerung filed Critical Asta Medica Ag
Publication of LTIP1488A publication Critical patent/LTIP1488A/en
Publication of LT3804B publication Critical patent/LT3804B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LTIP1488A 1989-09-27 1993-11-25 Process for preparing pharmaceutical preparation for treating psoriatic diseases LT3804B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3932183 1989-09-27

Publications (2)

Publication Number Publication Date
LTIP1488A true LTIP1488A (en) 1995-06-26
LT3804B LT3804B (en) 1996-03-25

Family

ID=6390272

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP1488A LT3804B (en) 1989-09-27 1993-11-25 Process for preparing pharmaceutical preparation for treating psoriatic diseases

Country Status (17)

Country Link
EP (2) EP0916343A1 (en)
JP (1) JP3176615B2 (en)
CA (1) CA2026278C (en)
DD (1) DD298052A5 (en)
DE (1) DE4029747C2 (en)
EG (1) EG19338A (en)
FI (1) FI904726A0 (en)
HU (1) HU209589B (en)
IE (1) IE903464A1 (en)
LT (1) LT3804B (en)
LV (1) LV10391B (en)
MC (1) MC2150A1 (en)
NO (1) NO904184L (en)
PT (1) PT95422B (en)
RU (1) RU1837877C (en)
UA (1) UA19335A (en)
ZA (1) ZA907702B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958906A (en) * 1992-10-01 1999-09-28 Asta-Medica Aktiengesellschaft Phospholipid derivatives containing higher elements of the fifth main group
DE4233044A1 (en) * 1992-10-01 1994-04-07 Asta Medica Ag Phospholipid derivatives that contain higher elements of the 5th main group
DE4235911A1 (en) * 1992-10-23 1994-04-28 Asta Medica Ag Stabilized hexadecylphosphocholine solutions in glycerol alkyl ethers
HUP0004363A3 (en) * 1998-01-22 2002-12-28 Zentaris Gmbh Solid pharmaceutical compositions containing miltefosine for use in the treatment of leishmaniasis
DE102006004821B4 (en) * 2006-01-30 2020-12-10 Cuma Kilic Collection container for waste and building rubble
EA021785B1 (en) * 2009-07-09 2015-08-31 Пауль Менг Liquid pharmaceutical form of alkylphosphocholine and method of preparing same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761404A (en) * 1985-07-01 1988-08-02 Merck & Co., Inc. Phospholipid analogs useful as PAF synthesis inhibitors
IE59777B1 (en) * 1985-12-04 1994-04-06 Max Planck Gesellschaft Medicaments
DE3829899C2 (en) * 1988-09-02 1994-12-15 Reutter Werner Glycerine glycophosphatides and pharmaceutical compositions containing them for combating skin diseases

Also Published As

Publication number Publication date
NO904184D0 (en) 1990-09-26
DE4029747C2 (en) 2003-10-02
HU906233D0 (en) 1991-03-28
EP0419998A2 (en) 1991-04-03
RU1837877C (en) 1993-08-30
EP0419998A3 (en) 1991-10-23
LV10391B (en) 1995-10-20
JPH03130228A (en) 1991-06-04
EP0916343A1 (en) 1999-05-19
DE4029747A1 (en) 1991-04-11
PT95422B (en) 1997-07-31
MC2150A1 (en) 1992-03-10
HU209589B (en) 1994-08-29
JP3176615B2 (en) 2001-06-18
DD298052A5 (en) 1992-02-06
PT95422A (en) 1991-05-22
LT3804B (en) 1996-03-25
CA2026278C (en) 1996-04-30
NO904184L (en) 1991-04-02
HUT55992A (en) 1991-07-29
LV10391A (en) 1995-02-20
CA2026278A1 (en) 1991-03-28
FI904726A0 (en) 1990-09-26
UA19335A (en) 1997-12-25
IE903464A1 (en) 1991-04-10
ZA907702B (en) 1991-07-31
EG19338A (en) 1994-12-30

Similar Documents

Publication Publication Date Title
HU907339D0 (en) Process for treating diseases
HU906006D0 (en) Process for the preparation of medical products
HUT54491A (en) Quickly soluble pharmaceutical unit dosage and process for producing same
HUT50445A (en) Process for producing pharmaceutical compositions suitable for preventing sexual diseases
HUT54046A (en) Process for producing pharmaceutical compositions
HU900041D0 (en) Process for preparation of thiazole-derivatives
HUT53655A (en) Process for producing pharmaceutical compositions suitable for treating hiv-infected patients
HU903486D0 (en) Process for producing halogene-substituted diphenyl-sulfides and pharmaceutical preparatives containing these compounds
HUT47846A (en) Process for producing antimalarian pharmaceutical
HU906498D0 (en) Process for producing new aryloxy-alcoyl-benzenes and pharmaceutical preparatives containing these compounds
HU9200821D0 (en) Process for the production of medical preparation containing tioredoxine
HUT53802A (en) Process for producing pharmaceutical preparations containing piperidino-alkanole-derivatives
HU900040D0 (en) Process for preparation of (pyrrolil-phenyl)-substituted-hydroxamacid-derivatives
LTIP1488A (en) Process for preparing pharmaceutical preparation for treating psoriatic diseases
HUT48591A (en) Process for producing new fluoromethoxyphenyl-dihydro-pyridines and pharmaceutical compositions comprising these compounds
ZA882783B (en) Process for preparing a pharmaceutical composition
HU902047D0 (en) Process for the preparation of pharmaceutical product
EG19075A (en) A process for preparing a pharmaceutical preparation in the treatment of tonsillitis
PT84755A (en) Process for the preparation of a pharmaceutical composition for the treatment of skin diseases
HK123396A (en) New broncho-spasmolytic compounds and process for their preparation
GB8824694D0 (en) New isopolypeptides & process for preparation thereof
HUT59827A (en) Process for producing pharmaceutical compositions containing pafantagonistic thieno-triazolo-diazepines for treating heart diseases produced by diminished beta-receptor-stimulant
HU907129D0 (en) Process for producing pharmaceutical preparatives
HUT55636A (en) Process for producing pharmaceutical composition
HU905853D0 (en) Process for the preparation of medical products containing dopamine-autoreceptor-antagonists for treating drug dependence